文献速递乳房整形与再造创面修复

预防性可吸收抗生素骨水泥联合口服抗生素用于乳房再造的多中心研究

Prophylactic absorbable antibiotic-loaded cement and oral antibiotics for breast reconstruction: A multi-institutional study.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2026-07-03

该多中心回顾性研究比较了组织扩张器乳房再造中应用抗生素骨水泥时加用或不加用术后口服抗生素的效果。共纳入253例患者(402侧乳房),结果显示两组手术部位感染率和组织扩张器取出率无显著差异,提示口服抗生素与抗生素骨水泥无协同作用,支持省略术后抗生素。

要点

  • 抗生素骨水泥联合口服抗生素未降低手术部位感染率(1.1% vs 2.3%,p=0.3907)。
  • 组织扩张器取出率两组无显著差异(2.2% vs 6.2%,p=0.0752)。
  • 结果支持在组织扩张器再造中省略术后口服抗生素。

核心结论

  • 口服抗生素与抗生素骨水泥联合使用时无协同效应。
  • 数据支持在组织扩张器乳房再造中省略术后口服抗生素。

研究设计与样本

  • 多中心回顾性研究,纳入2019至2025年在两个学术中心接受乳房切除、即刻胸肌前组织扩张器再造并放置可吸收抗生素骨水泥的患者。
  • 共253例患者(402侧乳房),分为组1(无术后口服抗生素,178例273侧)和组2(术后口服抗生素2周,75例129侧),两组均接受围手术期静脉抗生素。

主要发现

  • 手术部位感染发生率组1为1.1%,组2为2.3%(p=0.3907)。
  • 组织扩张器取出率组1为2.2%,组2为6.2%(p=0.0752)。

临床怎么用

  • 在胸肌前组织扩张器再造并应用抗生素骨水泥时,可考虑省略术后口服抗生素。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 样本量有限,组间事件数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Implant infection is common in breast reconstruction. Infection rates up to 10- 24% following reconstruction using tissue expanders (TEs) have been reported. Prophylactic absorbable antibiotic calcium sulfate (CS) cement is known to decrease infection in TE reconstruction. Oral antibiotics are not proven to prevent TE infection. However, it is unknown if oral antibiotics when used concurrently with absorbable antibiotic cement may be synergistic. The purpose of this study was to compare TE reconstruction outcomes using antibiotic-loaded CS with and without postoperative oral antibiotics. A multi-institutional retrospective study of patients who underwent mastectomy, immediate prepectoral TE reconstruction, and placement of absorbable antibiotic-loaded CS cement at two academic centers was performed (2019-2025). Patients were divided into two groups: Group 1 (TE, antibiotic CS, and no postoperative oral antibiotics) and Group 2 (TE, antibiotic CS, and 2 weeks of postoperative oral antibiotics). Both groups received perioperative intravenous antibiotics. Surgical-site infection and TE loss were the variables of interest. The study included 253 patients (402 total breasts) who underwent prepectoral TE reconstruction and received absorbable antibiotic CS. There were 178 patients in Group 1 (273 breasts) and 75 patients (129 breasts) in Group 2. Surgical-site infection occurred in 1.1% of Group 1 compared to 2.3% of Group 2 (p=0.3907). TE removal was performed in 2.2% of Group 1 compared to 6.2% in Group 2 (p=0.0752). Oral antibiotics do not have a synergistic effect when combined with antibiotic eluting absorbable cement. These data further support the recommendations to omit postoperative antibiotics with TE reconstruction.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Ahmed S, Sidhu A, Nguyen A, et al. Prophylactic absorbable antibiotic-loaded cement and oral antibiotics for breast reconstruction: A multi-institutional study. J Plast Reconstr Aesthet Surg. 2026. PMID: 42447676. doi:10.1016/j.bjps.2026.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。